We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

9 hedge funds and large institutions have $17.3M invested in TriSalus Life Sciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

86.76% less ownership

Funds ownership: 93.64% → 6.88% (-87%)

88% less funds holding

Funds holding: 72 → 9 (-63)

92% less capital invested

Capital invested by funds: $225M → $17.3M (-$207M)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 64

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
9
Holders Change
-63
Holders Change %
-87.5%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
64
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$124K
2
UBS Group
UBS Group
Switzerland
+$20.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$27.1M
2
DM
Deerfield Management
New York
-$9.93M
3
GCL
Glazer Capital LLC
New York
-$9.56M
4
Marshall Wace
Marshall Wace
United Kingdom
-$7.9M
5
HSBC Holdings
HSBC Holdings
United Kingdom
-$7.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIMCA
51
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$1.13M -113,575 Closed
WRBC
52
W.R. Berkley Corp
Connecticut
– -$1.02M -102,476 Closed
LCM
53
Landscape Capital Management
New Jersey
– -$993K -99,985 Closed
CM
54
Cohanzick Management
New York
– -$986K -99,269 Closed
Blackstone Inc
55
Blackstone Inc
New York
– -$765K -77,005 Closed
SSA
56
Schonfeld Strategic Advisors
New York
– -$695K -69,940 Closed
CC
57
Centiva Capital
New York
– -$662K -66,711 Closed
PAMP
58
Polar Asset Management Partners
Ontario, Canada
– -$553K -55,707 Closed
AWG
59
Alpha Wave Global
New York
– -$535K -53,857 Closed
LA
60
Linden Advisors
New York
– -$535K -53,782 Closed
WA
61
Whitebox Advisors
Minnesota
– -$522K -52,604 Closed
TIM
62
Timelo Investment Management
Ontario, Canada
– -$497K -50,000 Closed
COPPSERS
63
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$399K -40,200 Closed
E
64
Ergoteles
New York
– -$387K -38,940 Closed
GH
65
GAM Holding
Switzerland
– -$318K -32,000 Closed
OFG
66
OTA Financial Group
New York
– -$298K -30,051 Closed
GCWM
67
Graham Capital Wealth Management
District of Columbia
– -$271K -27,311 Closed
TCM
68
Tenor Capital Management
New York
– -$199K -20,000 Closed
CI Investments Inc
69
CI Investments Inc
Ontario, Canada
– -$193K -19,400 Closed
Walleye Capital
70
Walleye Capital
New York
– -$128K -12,898 Closed
ACA
71
Arena Capital Advisors
California
– -$43K -4,287 Closed
AA
72
Ancora Advisors
Ohio
– -$21K -2,098 Closed
EC
73
Elequin Capital
New York
– -$10K -1,000 Closed
1 2
3

TLSI Hedge Fund Activity: Q4 2022 in Review

9 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q4 2022, worth a combined $17.3M — down 92% from $225M a quarter earlier.

Sellers outnumbered buyers: 64 funds closed out of TLSI and 1 opened new positions — a net loss of 63 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $124K. The largest seller was BlackRock, exiting entirely with an estimated $27.1M sold.

  • 9 institutional investors held TriSalus Life Sciences (TLSI) as of Q4 2022, down from 72 in Q3 2022.
  • Funds reported $17.3M of TriSalus Life Sciences stock for Q4 2022, down 92% quarter-over-quarter.
  • 1 fund opened new TriSalus Life Sciences positions in Q4 2022 and 64 closed out, a net change of -63 holders.
  • The largest TriSalus Life Sciences buyer in Q4 2022 was Virtu Financial, an estimated $124K added.
  • The largest TriSalus Life Sciences seller in Q4 2022 was BlackRock, an estimated $27.1M sold.

Based on aggregated 13F filings for Q4 2022.